Author Search Results

1

Caractérisation clinique et biologique de l’hyperprogression tumorale lors du blocage de la voie PD-1/PD-L1

by Champiat, Stéphane
Published 2019

Get full text

2

Durvalumab for the management of urothelial carcinoma: a short review on the emerging data and therapeutic potential

by Baldini C, Champiat S, Vuagnat P, Massard C
Published 2019-04-01

Get full text

Article

3

Beyond the Driver Mutation: Immunotherapies in Gastrointestinal Stromal Tumors

by Matthieu Roulleaux Dugage, Robin Lewis Jones, Jonathan Trent, Stéphane Champiat, Sarah Dumont
Published 2021-08-01

Get full text

Article

4

Anti-PD-1 Vasculitis of the central nervous system or radionecrosis?

by Roger Sun, Francois-Xavier Danlos, Samy Ammari, Guillaume Louvel, Frédéric Dhermain, Stéphane Champiat, Olivier Lambotte, Eric Deutsch
Published 2017-12-01

Get full text

Article

5

Evidence of pseudoprogression in patients treated with PD1/PDL1 antibodies across tumor types

by Patricia Martin‐Romano, Eduardo Castanon, Samy Ammari, Stéphane Champiat, Antoine Hollebecque, Sophie Postel‐Vinay, Capucine Baldini, Andrea Varga, Jean Marie Michot, Perrine Vuagnat, Aurélien Marabelle, Jean‐Charles Soria, Charles Ferté, Christophe Massard
Published 2020-04-01

Get full text

Article

6

Role of Cardiac Imaging in the Diagnosis of Immune Checkpoints Inhibitors Related Myocarditis

by Stéphane Ederhy, Stéphane Ederhy, Joe-Elie Salem, Joe-Elie Salem, Joe-Elie Salem, Joe-Elie Salem, Laurent Dercle, Abrar Saqif Hasan, Marion Chauvet-Droit, Pascal Nhan, Samy Ammari, Samy Ammari, Bruno Pinna, Alban Redheuil, Samia Boussouar, Stephane Champiat, Laurie Soulat-Dufour, Ariel Cohen, Ariel Cohen
Published 2021-05-01

Get full text

Article

7

Human Endogenous Retrovirus Expression Is Upregulated in the Breast Cancer Microenvironment of HIV Infected Women: A Pilot Study

by Gislaine Curty, Greta A. Beckerle, Luis P. Iñiguez, Robert L. Furler, Pedro S. de Carvalho, Jez L. Marston, Stephane Champiat, Jonas J. Heymann, Christopher E. Ormsby, Gustavo Reyes-Terán, Marcelo A. Soares, Douglas F. Nixon, Matthew L. Bendall, Fabio E. Leal, Miguel de Mulder Rougvie
Published 2020-10-01

Get full text

Article

8

359 AMG 757, a half-life extended bispecific T-cell engager (BiTE®) immune therapy against DLL3 in SCLC: phase 1 interim results

by Hui Yang, Stephane Champiat, Ramaswamy Govindan, Ravi Salgia, Fiona Blackhall, Everett Vokes, Michael Boyer, Marie-Anne Damiette Smit, Melissa Johnson, Hossein Borghaei, Luis Paz-Ares Rodrigues, Rene Boosman, Horst-Dieter Hummel, W Victoria Lai, Hibiki Udagawa, Anne Chiang, Christine Hann, Mukul Minocha, Nooshin Hashemi-Sadraei, Aditya Shetty, Taofeek Owonikoko
Published 2020-11-01

Article

9

Influence of HAART on alternative reading frame immune responses over the course of HIV-1 infection.

by Stephane Champiat, Rui André Saraiva Raposo, Nicholas J Maness, John L Lehman, Sean E Purtell, Aaron M Hasenkrug, Jacob C Miller, Hansi Dean, Wayne C Koff, Marisa Ailin Hong, Jeffrey N Martin, Steven G Deeks, Gerald E Spotts, Christopher D Pilcher, Fredrick M Hecht, Esper G Kallas, Keith E Garrison, Douglas F Nixon
Published 2012-01-01

Get full text

Article

10

Safety, recommended dose, efficacy and immune correlates for nintedanib in combination with pembrolizumab in patients with advanced cancers

by Abbassi, A., Adam, J., Bahleda, R., Baldini, C., Bigorgne, A., Boselli, L., Bredel, D., Cassard, L., Champiat, S., Chaput, N., Danlos, F.-X, Escriou, G., Farhane, S., Gazzah, A., Grivel, J., Grynszpan, L., Halse, H., Hollebecque, A., Lacroix, L., Laghouati, S., Marabelle, A., Martin-Romano, P., Massard, C., Michot, J.-M, Mohamed-Djalim, C., Mouraud, S., Parpaleix, A., Postel-Vinay, S., Rafie, S., Ribrag, V., Signolle, N., Soria, J.-C, Susini, S., Texier, M., Varga, A., Vuagnat, P., Zitvogel, L.
Published 2022

View Fulltext in Publisher

Article

Related Subjects